← FDA Drug Approvals (Drugs@FDA)

SUCCINYLCHOLINE CHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2020-12-21

Drug application

FDA Application #
ANDA214491
Application type
Abbreviated New Drug Application (Generic)
Brand name
SUCCINYLCHOLINE CHLORIDE
Generic name
SUCCINYLCHOLINE CHLORIDE
Active ingredients
SUCCINYLCHOLINE CHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
DEVA HOLDING AS
Manufacturer
Devatis, Inc.
First approval
2020-12-21

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown